Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |